VF
ARLZ

Virtu Financial’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Virtu Financial’s Portfolio ARLZ Stock Details ARLZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-60,565
Closed -$91K – 2862
2018
Q1 		$91K Buy
60,565
+17,525
+41% +$30.6K ﹤0.01% 1600
2017
Q4 		$61K Buy
43,040
+13,572
+46% +$22.3K ﹤0.01% 2045
2017
Q3 		$67K Buy
+29,468
New +$39.4K ﹤0.01% 2169

Other funds holding ARLZ

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
SM
Salzhauer Michael $292M AUM 30% 1-Year Est. Return
PCM
PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
SCP
Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return
FSA
Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Virtu Financial's ARLZ Position: Q2 2018 in Review

Virtu Financial sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 60,565 shares — an estimated $91K sold.

Virtu Financial first reported a position in ARLZ in Q3 2017 and held it in 3 quarters. The position peaked at $91K in Q1 2018. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

  • Virtu Financial reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
  • Virtu Financial sold 60,565 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $91K.
  • Virtu Financial first reported a position in Aralez Pharmaceuticals Inc. in Q3 2017 and held it in 3 quarters.
  • Virtu Financial's Aralez Pharmaceuticals Inc. position peaked at $91K in Q1 2018.
  • 48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.